Albany – NY, Oct. 20, 2015 (GLOBE NEWSWIRE) — The CDC estimates that the global prevalence of atrial fibrillation will approximate 12 million by 2050, growing alarmingly from 2.66 million in 2010. This creates a conducive setting for the growth of the global atrial fibrillation market, which will exhibit a CAGR of 13.4% from 2013 through 2019, states Transparency Market Research in its latest report. The report is titled ‘Atrial Fibrillation Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.’ The report values the global atrial fibrillation market at US$ 6.1 billion as of 2012, and projects it to expand to US$14.8 billion by 2019.
Browse Market Research Report on Atrial Fibrillation Market:
The report segments the global atrial fibrillation market by geography into the following regions: Asia Pacific, North America, Europe and Rest of the World (RoW). Because of the high pervasiveness of atrial fibrillation in North America, the market in this region was reported as being the largest in 2012 and commanded a superior share of both demand and revenues. The factors that have helped North America sustain an edge in the global atrial fibrillation market are: Patients with high disposable income, a high degree of prevalence of atrial fibrillation, favorable and uncomplicated reimbursement procedures, and higher budgets being allocated toward healthcare. Europe held the second largest market share in 2012. While Asia Pacific currently doesn’t stand as the most influential atrial fibrillation market, it does show immense growth potential and has been identified as the fastest-growing market (based on CAGR) because a rise in atrial fibrillation cases in China is being reported. Healthcare reforms brought about as a result of the rapid economic growth of certain countries in APAC will work in favor of the APAC atrial fibrillation market.
The market for atrial fibrillation can be segmented on the basis of treatment types as: Pharmacological and non-pharmacological. While pharmacological treatment is classified as anti-coagulant and anti-arrhythmic drugs, the non-pharmacological treatment market is composed of catheter ablation, maze surgery and electric cardioversion. The report drills deeper into the catheter ablation treatment segment by dividing it thus: Radiofrequency-, cryoablation-, HIFU-, microwave-, and laser-based catheter ablation.Pharmacological treatment procedures were dominant in the global atrial fibrillation market in 2012. This is because pharmacological treatment is often administered to patients alongside non-pharmacological treatment. For instance, a patient may be administered anti-coagulant drugs ahead of an electric cardioversion. In some cases, patients are asked to take anti-coagulants following procedures that involve catheter ablation to mitigate the risk of stroke.
Get Sample Report Copy of Atrial Fibrillation Market:
More importantly, as compared to non-pharmacological procedures, drugs are a more affordable option. However, this aspect doesn’t always come into play because a cardiologist may sometimes recommend the former and atrial fibrillation patients necessarily have to go with the surgeon’s advice.
As a result of these factors, pharmacological atrial fibrillation procedures are expected to account for about 55% of the entire market by 2019. Growth will be encouraged with the launch of new anti-coagulants such as rivaroxaban and dabigatran. The launch of other new drugs such as NTC-801 (Bristol Myer Squibb), Vernakalant (Merck), and Pradaxa (Boehringer Ingelheim) will augur well for the atrial fibrillation pharmacological treatment procedures market.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
CONTACT: Mr. Nachiket Ghumare State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: firstname.lastname@example.org Website: http://www.transparencymarketresearch.com